|
|
|
Volumn 360, Issue 17, 2009, Pages 1790-
|
|
More on reports of esophageal cancer with oral bisphosphonate use
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BISPHOSPHONIC ACID DERIVATIVE;
BONE DENSITY CONSERVATION AGENT;
BARRETT ESOPHAGUS;
COMORBIDITY;
DISEASE DURATION;
ESOPHAGEAL ADENOCARCINOMA;
HUMAN;
LETTER;
OSTEOPOROSIS;
POSTMENOPAUSE;
PRIORITY JOURNAL;
ADENOCARCINOMA;
CHEMICALLY INDUCED DISORDER;
ESOPHAGUS TUMOR;
FEMALE;
NOTE;
ORAL DRUG ADMINISTRATION;
POSTMENOPAUSE OSTEOPOROSIS;
TIME;
ADENOCARCINOMA;
ADMINISTRATION, ORAL;
BARRETT ESOPHAGUS;
BONE DENSITY CONSERVATION AGENTS;
DIPHOSPHONATES;
ESOPHAGEAL NEOPLASMS;
FEMALE;
HUMANS;
OSTEOPOROSIS, POSTMENOPAUSAL;
TIME FACTORS;
|
|
EID: 65949105057
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (6)
|
|
References (0)
|
